2 domains / 3 areas / 3 specializations
Oregon Health Authority Pharmacy & Therapeutics Committee
Data updated
State-level Oregon pharmacy and therapeutics decision body supporting evidence-driven formulary and utilization policy.
Reimbursement & Market Access Snapshot
Health EconomistsService Model
HTA / Value Assessment Body
Jurisdiction
Subnational / State-Level
Coverage
1 country
Last Verified
Apr 11, 2026
Focus Areas
Evidence Requirements
Market Access Notes
Oregon P&T and OHA advisory packets include detailed prior-authorization criteria and evidence review content for Spravato/esketamine.
Verification
Verified
Psychedelic Focus
Explicit Psychedelic Focus
Engagement Status
Active
Verification Notes
Verified with explicit Spravato/esketamine sections in Oregon P&T and OHA MHCAG meeting packets.
Linked Stakeholders
Source Evidence
Public Sector Governance Snapshot
Health Technology Assessment AgenciesAuthority Type
Health Technology Assessment Agency
Jurisdiction
Subnational / State-Level
Coverage
1 country
Framework Status
Active
Function Areas
Governance Notes
Wave 2 governance enrichment for Oregon Health Authority Pharmacy & Therapeutics Committee.
Verification
Verified
Psychedelic Engagement
Psychedelic-Adjacent Focus
Last Verified
Apr 13, 2026
Quick Facts
- Website
- Visit